Cell Surface Absence of an Interaction between pMHCI on CTL Activation and Occurs in the Binding : This Is Paralleled by Their Effects Peptide-MHC Class I ( pMHCI ) Multimer Anti-CD 8 Antibodies Can Inhibit or Enhance

[1]  P. Baumgaertner,et al.  The β1 and β3 Integrins Promote T Cell Receptor-mediated Cytotoxic T Lymphocyte Activation* , 2003, Journal of Biological Chemistry.

[2]  Andrew K. Sewell,et al.  The CD8 T Cell Coreceptor Exhibits Disproportionate Biological Activity at Extremely Low Binding Affinities* , 2003, Journal of Biological Chemistry.

[3]  D. Legler,et al.  Soluble Major Histocompatibility Complex-Peptide Octamers with Impaired CD8 Binding Selectively Induce Fas-dependent Apoptosis* 210 , 2003, The Journal of Biological Chemistry.

[4]  David M Kranz,et al.  Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. , 2003, Immunity.

[5]  O. Michielin,et al.  CD3δ Establishes a Functional Link between the T Cell Receptor and CD8* , 2003, The Journal of Biological Chemistry.

[6]  H. Ploegh,et al.  Mouse MHC class I tetramers that are unable to bind to CD8 reveal the need for CD8 engagement in order to activate naive CD8 T cells , 2002, European journal of immunology.

[7]  V. Cerundolo,et al.  The use of chimeric A2K(b) tetramers to monitor HLA A2 immune responses in HLA A2 transgenic mice. , 2002, Journal of immunological methods.

[8]  E. Palmer,et al.  A Role for the α-Chain Connecting Peptide Motif in Mediating TCR-CD8 Cooperation , 2002, The Journal of Immunology.

[9]  Andrew K. Sewell,et al.  Novel CD8+ T Cell Antagonists Based on β2-Microglobulin* , 2002, The Journal of Biological Chemistry.

[10]  P. Rod Dunbar,et al.  Competition Between CTL Narrows the Immune Response Induced by Prime-Boost Vaccination Protocols1 , 2002, The Journal of Immunology.

[11]  R. König.  Interactions between MHC molecules and co-receptors of the TCR. , 2002, Current opinion in immunology.

[12]  Ian A Wilson,et al.  The specificity of TCR/pMHC interaction. , 2002, Current opinion in immunology.

[13]  F. Wurm,et al.  CD8β Endows CD8 with Efficient Coreceptor Function by Coupling T Cell Receptor/CD3 to Raft-associated CD8/p56lck Complexes , 2001, The Journal of experimental medicine.

[14]  A. Sewell,et al.  An inter-species difference in the CD8 coreceptor , 2001 .

[15]  Ellis L. Reinherz,et al.  Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Andrew K. Sewell,et al.  The Human CD8 Coreceptor Effects Cytotoxic T Cell Activation and Antigen Sensitivity Primarily by Mediating Complete Phosphorylation of the T Cell Receptor ζ Chain* , 2001, The Journal of Biological Chemistry.

[17]  Y. Reiter,et al.  Critical Role for CD8 in Binding of MHC Tetramers to TCR: CD8 Antibodies Block Specific Binding of Human Tumor- Specific MHC-Peptide Tetramers to TCR1 , 2001, The Journal of Immunology.

[18]  T. Braciale,et al.  Cutting Edge: Lipid Raft Integrity Affects the Efficiency of MHC Class I Tetramer Binding and Cell Surface TCR Arrangement on CD8+ T Cells1 , 2001, The Journal of Immunology.

[19]  Ellis L. Reinherz,et al.  T Cell Receptor Binding to a pMHCII Ligand Is Kinetically Distinct from and Independent of CD4* , 2001, The Journal of Biological Chemistry.

[20]  E. Palmer,et al.  Essential Role of CD8 Palmitoylation in CD8 Coreceptor Function1 , 2000, The Journal of Immunology.

[21]  C. Tournay,et al.  Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding , 2000, Nature Medicine.

[22]  David I. Stuart,et al.  Classical and Nonclassical Class I Major Histocompatibility Complex Molecules Exhibit Subtle Conformational Differences That Affect Binding to CD8αα* , 2000, The Journal of Biological Chemistry.

[23]  S. Jameson,et al.  Critical Role for Cd8 in T Cell Receptor Binding and Activation by Peptide/Major Histocompatibility Complex Multimers , 2000, The Journal of experimental medicine.

[24]  D. Price,et al.  Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent. , 1999, Journal of immunology.

[25]  G. Ogg,et al.  Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma. , 1999, Journal of immunology.

[26]  A. Lanzavecchia,et al.  Developmental Regulation of Lck Targeting to the CD8 Coreceptor Controls Signaling in Naive and Memory T Cells , 1999, The Journal of experimental medicine.

[27]  H. Etlinger,et al.  the Journal of Immunology , 2006 .

[28]  A. Hamad,et al.  Potent T Cell Activation with Dimeric Peptide–Major Histocompatibility Complex Class II Ligand: The Role of CD4 Coreceptor , 1998, The Journal of experimental medicine.

[29]  J. Altman,et al.  Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected]. , 1998, Immunity.

[30]  P. Marrack,et al.  Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. , 1998, Immunity.

[31]  G. Ogg,et al.  Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood , 1998, Current Biology.

[32]  R. Zamoyska,et al.  Co‐capping studies reveal CD8/TCR interactions after capping CD8β polypeptides and intracellular associations of CD8 with p56lck , 1998, European journal of immunology.

[33]  Y. Chien,et al.  CD4 augments the response of a T cell to agonist but not to antagonist ligands. , 1997, Immunity.

[34]  R. Phillips,et al.  Antagonism of cytotoxic T lymphocyte‐mediated lysis by natural HIV‐1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides , 1997, European journal of immunology.

[35]  D. Stuart,et al.  Crystal structure of the complex between human CD8αα and HLA-A2 , 1997, Nature.

[36]  R. Zamoyska,et al.  Is CD8 dependence a true reflection of TCR affinity for antigen? , 1993, International immunology.

[37]  D. Kranz,et al.  Role of CD8 in staphylococcal enterotoxin B-mediated lysis by cytotoxic T lymphocytes. , 1993, Journal of immunology.

[38]  R. Germain,et al.  MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8 , 1992, Nature.

[39]  J. Guardiola,et al.  Identification of a CD4 binding site on the β2 domain of HLA-DR molecules , 1992, Nature.

[40]  P. Parham,et al.  CD8 independence and specificity of cytotoxic T lymphocytes restricted by HLA-Aw68. 1 , 1991, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[41]  A. Vitiello,et al.  Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex , 1991, The Journal of experimental medicine.

[42]  N. Shastri,et al.  Requirement for association of p56 lck with CD4 in antigen-specific signal transduction in T cells , 1991, Cell.

[43]  S. Spencer,et al.  Epitope-specific binding of CD8 regulates activation of T cells and induction of cytotoxicity. , 1990, International immunology.

[44]  P. Parham,et al.  A binding site for the T-cell co-receptor CD8 on the α3 domain of HLA-A2 , 1990, Nature.

[45]  S. D. Gorman,et al.  Inability of CD8α′polypeptides to associate with p56 lck correlates with impaired function in vitro and lack of expression in vivo , 1989, Nature.

[46]  P. Parham,et al.  Polymorphism in the α3 domain of HLA-A molecules affects binding to CD8 , 1989, Nature.

[47]  J. Gabert,et al.  Reconstitution of MHC class I specificity by transfer of the T cell receptor and Lyt-2 genes , 1987, Cell.

[48]  A. Kelso,et al.  Clonal Heterogeneity in the Functional Requirement for Lyt‐2/3 Molecules on Cytolytic T Lymphocytes (CTL): Possible Implications for the Affinity of CTL Antigen Receptors , 1982, Immunological reviews.

[49]  R. Hoffman,et al.  Simple and rapid measurement of human T lymphocytes and their subclasses in peripheral blood. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[50]  A. Necker,et al.  Human CD8 co-receptor is strictly involved in MHC-peptide tetramer-TCR binding and T cell activation. , 2002, International immunology.

[51]  V. Appay,et al.  A Novel Approach to Antigen-Specific Deletion of CTL with Minimal Cellular Activation Using a 3 Domain Mutants of MHC Class I / Peptide Complex express , 2001 .

[52]  J. Bell,et al.  BirA enzyme: production and application in the study of membrane receptor-ligand interactions by site-specific biotinylation. , 1999, Analytical biochemistry.

[53]  Mark M. Davis,et al.  LIGAND RECOGNITION BY T CELL RECEPTORS , 1998 .

[54]  鈴木 聡.  Biochemical evidence of the physical association of the majority of CD3 δ chains with the accessory/co-receptor molecules CD4 and CD8 on nonactivated T lymphocytes , 1994 .